Cisco Systems Inc vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Cisco Systems Inc trades at $118.34 (market cap $452.96B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Cisco Systems Inc is far larger — about 36× Halozyme Therapeutics Inc. Common Stock's market cap, and Cisco Systems Inc pays a 1.46% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cisco Systems Inc for 86 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| CSCO | HALO | |
|---|---|---|
Market Cap | $452.96B | $12.58B |
Volume | 12,951,578 | 2,179,278 |
Sector | Technology | Health |
52-Week High | $130.00 | $115.22 |
52-Week Low | $67.46 | $61.63 |
Typical Hold Time | 86 Days | 1 Days |
Enterprise Value | $466.58B | $14.49B |
Dividend Yield | 1.46% | — |
Signals from Pluang's Aura AI — not financial advice
Cisco Systems (CSCO) trades at $117.39, down 0.47% on the day, with a bullish technical signal from moving averages but overbought short-term RSI. The company reported strong Q2 2026 earnings, beating estimates with EPS of $1.22, and revenue growth is supported by AI-driven networking demand. Valuation ratios are elevated with a P/E of 34.5, while profitability remains robust with a net income margin of 20.95%.
The outlook is positive given AI infrastructure growth and consistent earnings beats, but high valuation and competitive pressures pose risks. Analyst consensus is bullish with a $129.77 price target, implying potential upside. Key risks include execution challenges in integrating AI innovations and macroeconomic sensitivity.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cisco Systems, Inc. provides information technology and networking services. The Company offers enterprise network security, software development, data collaboration, cloud computing, and other related services. Cisco Systems serves customers in the United States.
Read more on CSCO →Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →